What is Barclays's price target for PATH?

Barclays's latest stated price target for UiPath Inc. (PATH) is $15, from its action on Oct 18, 2022.

What is Barclays's rating on PATH?

Barclays rates PATH Equal Weight, a neutral rating, as of Oct 18, 2022.

When did Barclays last change its view on PATH?

On Oct 18, 2022, Barclays downgrades to Equal Weight from Overweight, price target $17 to $15.

Barclays PATH price target and rating history

Barclays rates UiPath Inc. (PATH) Equal Weight with a $15 price target, as of its latest action on Oct 18, 2022. It has published 5 rating actions on PATH since September 2021, including 2 upgrades and 1 downgrade. Across 4 firms with a PATH price target in the last 12 months, the median target is $15.

Current rating: Equal Weight
Price target: $15
Median target, all firms: $15
Actions on PATH: 5

Barclays price target on PATH

Barclays price target on PATH, each point a stated target, September 2021 to October 2022.

Every Barclays rating on PATH

Oct 18, 2022
DowngradeBarclays downgrades to Equal Weight from Overweight, price target $17 to $15
Dec 9, 2021
ReiterateBarclays cuts its price target to $61 from $71, keeps Overweight
Sep 17, 2021
UpgradeBarclays upgrades to Overweight from Equal Weight, price target $70 to $71
Sep 17, 2021
UpgradeBarclays upgrades to Overweight from Equal-Weight
Sep 8, 2021
ReiterateBarclays cuts its price target to $70 from $73, keeps Equal-Weight

How other firms rate PATH

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
DA Davidson	Underperform	$10	Sep 28, 2026
BMO Capital Markets	Market Perform	$15	Sep 24, 2026
Canaccord Genuity	Hold	$17	Sep 4, 2026
Needham	Buy	$15	Mar 12, 2026

Questions about Barclays and PATH

What is Barclays's price target for PATH?: Barclays's latest stated price target for UiPath Inc. (PATH) is $15, from its action on Oct 18, 2022.
What is Barclays's rating on PATH?: Barclays rates PATH Equal Weight, a neutral rating, as of Oct 18, 2022.
When did Barclays last change its view on PATH?: On Oct 18, 2022, Barclays downgrades to Equal Weight from Overweight, price target $17 to $15.
How does Barclays's PATH target compare with other analysts?: Across 4 firms with a PATH price target in the last 12 months, the median target is $15.

More PATH rating histories

All Barclays ratings PATH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.